Strumento inattivo

Azioni Merus Labs International Inc

Azioni

Durata

Periodo

Stile

Merus Labs International : Norgine B.V. completes acquisition of Merus Labs International Inc. strengthening its leading position in the European specialist pharma market	17/07/17
Merus Labs International : Receives Court Approval in Connection with Proposed Plan of Arrangement with Norgine B.V.	13/07/17
Merus Labs International : Shareholders Approve Plan of Arrangement with Norgine B.V.	10/07/17
Merus Labs International : and Norgine B.V. receive Spanish anti-trust approval of proposed Arrangement of Fiscal Q1 2017 Earnings Release	04/07/17
Merus Labs International : and Norgine B.V. receive Spanish anti-trust approval of proposed Arrangement	04/07/17

Settore

	Variaz. 1 gen.	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20,93%	44,4 Mrd
OTSUKA HOLDINGS CO., LTD.	+24,52%	23,03 Mrd
SANDOZ GROUP AG	+18,00%	15,14 Mrd
CIPLA LIMITED	+12,88%	13,12 Mrd
ZYDUS LIFESCIENCES LIMITED	+43,91%	11,85 Mrd
ONO PHARMACEUTICAL CO., LTD.	-7,91%	6,99 Mrd
THE MEDICINES COMPANY	-0,05%	6,79 Mrd
STADA ARZNEIMITTEL	-8,87%	5,73 Mrd
ASPEN PHARMACARE HOLDINGS LIMITED	+12,22%	5,52 Mrd